Cube Biotech GmbH announced the appointment of Dr. Joachim Kreuzburg, former CEO and Chairman of the Executive Board of Sartorius AG, to its Board of Directors, effective July 3rd, 2025. 

Dr. Kreuzburg brings over two decades of executive leadership in the life sciences industry. During his tenure as CEO of Sartorius (2003–2025), the company expanded from a regional player into a global leader in bioprocessing, growing revenue from approximately €0.5 billion to approximately €3.5 billion and increasing the market capitalization of the group by a factor of approximately 150.

“We are honored to welcome Joachim to the Cube Biotech Board,” said Didier Dargent, Executive Chairman of Cube Biotech. “His strategic insights and deep sector expertise will be invaluable as we scale our global operations and advance our automation-driven capabilities in membrane protein technologies, purification and drug discovery.” 

Dr. Kreuzburg added: “Cube Biotech is building a powerful platform with world-class science, strong momentum, and an entrepreneurial team. I am excited to join the Board and support its journey to become a global leader in protein research.”